Summary
All extracted claims are marked as absent from the provided label content. No FDA-approved prescribing information sections were supplied, so there is no on-label support to verify any claims.
Category Scores
Accurate Statements
Unsupported Statements
Tretinoin is available in various formulations and concentrations.
Not supported by the provided FDA label content (absent from the label).
Its cost can differ significantly based on the specific product, dosage, quantity, and whether it is prescribed or purchased over-the-counter.
Not supported by the provided FDA label content (absent from the label).
Prescription tretinoin is typically more expensive than over-the-counter (OTC) versions.
Not supported by the provided FDA label content (absent from the label).
OTC versions of tretinoin may be available in lower concentrations.
Not supported by the provided FDA label content (absent from the label).
Brand-name tretinoin products can command higher prices than generic alternatives.
Not supported by the provided FDA label content (absent from the label).
Many insurance plans cover prescription tretinoin, reducing out-of-pocket expenses for patients.
Not supported by the provided FDA label content (absent from the label).
Without insurance, the cost can range from approximately $30 to over $200 for a tube, depending on factors mentioned.
Not supported by the provided FDA label content (absent from the label).
Prescription-strength tretinoin is available at local pharmacies and online pharmacies upon presentation of a valid prescription.
Not supported by the provided FDA label content (absent from the label).
A 30-gram tube of a generic tretinoin cream (0.025% or 0.05%) might cost between $40 and $100 without insurance.
Not supported by the provided FDA label content (absent from the label).
Over-the-counter tretinoin products are available in drugstores, beauty supply stores, and online retailers.
Not supported by the provided FDA label content (absent from the label).
OTC tretinoin products can contain 0.01% to 0.03% retinols or retinaldehyde.
Not supported by the provided FDA label content (absent from the label).
OTC options are generally less expensive than prescription versions.
Not supported by the provided FDA label content (absent from the label).
OTC prices range from $15 to $60 for a comparable amount.
Not supported by the provided FDA label content (absent from the label).
Many insurance providers cover tretinoin as a prescription medication for conditions like acne.
Not supported by the provided FDA label content (absent from the label).
Patients with insurance may have a co-pay that is significantly less than the full retail price.
Not supported by the provided FDA label content (absent from the label).
Discount cards and coupons offered by manufacturers or third-party discount providers can reduce out-of-pocket expense for both insured and uninsured individuals.
Not supported by the provided FDA label content (absent from the label).
Discounts can sometimes bring the cost down by 20% to 75%.
Not supported by the provided FDA label content (absent from the label).
Generic versions of tretinoin are widely available.
Not supported by the provided FDA label content (absent from the label).
Once brand-name patents expire, other pharmaceutical companies can produce and market generic versions of tretinoin.
Not supported by the provided FDA label content (absent from the label).
Generic formulations contain the same active ingredient and are therapeutically equivalent to their brand-name counterparts.
Not supported by the provided FDA label content (absent from the label).
Generic tretinoin is typically sold at a lower price than brand-name products.
Not supported by the provided FDA label content (absent from the label).
Prescription retinoids, including higher concentrations of tretinoin, are generally more expensive than over-the-counter retinoids like retinol and retinaldehyde.
Not supported by the provided FDA label content (absent from the label).
The specific formulation, brand, and concentration are key determinants of price across all retinoid types.
Not supported by the provided FDA label content (absent from the label).
Primary patents for the original tretinoin molecule have long expired, paving the way for generic competition.
Not supported by the provided FDA label content (absent from the label).
Contradictions
Important Omissions
FDA label-supported information on tretinoin’s approved indications, dosing/administration, contraindications, warnings/precautions, drug interactions, adverse reactions, and monitoring was not provided for evaluation (no label sections were supplied).
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
The provided content evaluates pricing/availability/insurance claims only; however, no FDA label content was available to verify product identity, OTC vs prescription status, or related safety labeling.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
All extracted claims lack support from the provided FDA label content (all marked absent from the label), and no label sections were supplied to verify correctness.
Suggested Improvement
Provide the actual FDA-approved prescribing information text/sections for tretinoin and restrict claims to those explicitly supported by the label.